The last 10 years have seen substantial growth in medical devices that can help people with diabetes to manage their condition, including the development of automated insulin delivery (AID) systems. Regulatory approval has been granted for the first AID systems, and a community of people living with type 1 diabetes has created its own systems using a do-it-yourself approach.
This consensus report from the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association offers a review of the current landscape of AID systems and recommends targeted actions.
The report covers the following areas:
- Setting the stage: using time in range to contextualise the impact of diabetes technologies
- A rapidly evolving landscape: benefits of AID systems
- Limitations of AID systems
- Education and expectations: a critical component of AID systems for both patients with diabetes and providers
- Patient perspective
- Provider perspective
- Special populations—what is needed?
- Considerations for patient selection for current AID systems
- Safety aspects to be considered for AID systems
- Cybersecurity, data privacy, data protection, General Data Protection Regulation, and data donation
- Evaluation and approval of AID systems in the US and Europe
- Access to AID systems
- DIY AID systems